LOGIN  |  REGISTER
C4 Therapeutics

Healthcare Services Group (NASDAQ: HCSG) Stock Quote

Last Trade: US$12.48 -0.05 -0.40
Volume: 338,564
5-Day Change: 0.81%
YTD Change: 20.35%
Market Cap: US$918.280M

Latest News From Healthcare Services Group

Exceeds Earnings and Cash Flow Expectations, Revenue In-Line Revenue of $423.8 million; adjusted revenue (1) of $425.0 million, in-line with expectations. Net income and diluted EPS of $22.6 million and $0.31; adjusted net income (1) and adjusted diluted EPS (1) of $14.6 million and $0.20. Adjusted EBITDA (1) of $26.5 million, a 14.2% increase over Q4 2022. Cash flow from operations of $49.5 million; adjusted cash flow from... Read More
Revenue of $411.4 million; adjusted revenue (1) of $424.0 million, in line with expectations. Net income and diluted EPS of ($5.5) million and ($0.07); adjusted net income (1) and adjusted diluted EPS (1) of $12.5 million and $0.17, a 13.7% and 13.3% increase, respectively, over Q3 2022. Adjusted EBITDA (1) of $23.2 million, a 10.2% increase over Q3 2022. Cash flow from operations of $2.9 million; adjusted cash flow from... Read More
Robust New Business Pipeline Sets Stage For Second Half Of Year Growth BENSALEM, Pa. / Jul 26, 2023 / Business Wire / Healthcare Services Group, Inc. (NASDAQ:HCSG) reported for the three months ended June 30, 2023 revenue of $418.9 million, GAAP net income of $8.6 million, or $0.12 per basic and diluted common share, and adjusted EBITDA of $26.3 million. Q2 Results Revenue for the quarter was reported at $418.9 million, with... Read More
Continues Positive Business Momentum, Adjusted EBITDA up 18% BENSALEM, Pa. / Apr 26, 2023 / Business Wire / Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended March 31, 2023 revenue of $417.2 million, GAAP net income of $12.7 million, or $0.17 per basic and diluted common share, and adjusted EBITDA of $27.5 million. Q1 Results Revenue for the quarter was reported at $417.2... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB